MD Rawlins

925 total citations
35 papers, 717 citations indexed

About

MD Rawlins is a scholar working on Pharmacology, Pharmacology and Oncology. According to data from OpenAlex, MD Rawlins has authored 35 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 10 papers in Pharmacology and 6 papers in Oncology. Recurrent topics in MD Rawlins's work include Pharmacogenetics and Drug Metabolism (8 papers), Inflammatory mediators and NSAID effects (5 papers) and Pharmaceutical studies and practices (4 papers). MD Rawlins is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Inflammatory mediators and NSAID effects (5 papers) and Pharmaceutical studies and practices (4 papers). MD Rawlins collaborates with scholars based in United Kingdom, Denmark and Portugal. MD Rawlins's co-authors include R. A. Seymour, H. Ashton, PA Routledge, K. W. Woodhouse, D. Nicholas Bateman, O.F.W. James, C. A. Edwards, Sam Shuster, Alan C. Ward and E Mutch and has published in prestigious journals such as British Journal of Clinical Pharmacology and Ecosystem Services.

In The Last Decade

MD Rawlins

34 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MD Rawlins United Kingdom 15 136 131 87 76 68 35 717
Michel Ollagnier France 15 105 0.8× 244 1.9× 89 1.0× 69 0.9× 61 0.9× 110 943
John A. H. Forrest United Kingdom 7 259 1.9× 91 0.7× 76 0.9× 53 0.7× 63 0.9× 11 681
Teresa Cabaleiro Spain 25 231 1.7× 113 0.9× 139 1.6× 123 1.6× 50 0.7× 57 1.3k
M. Lawrence Berman United States 15 292 2.1× 86 0.7× 52 0.6× 192 2.5× 40 0.6× 31 895
S Freestone United Kingdom 19 292 2.1× 183 1.4× 105 1.2× 325 4.3× 101 1.5× 58 1.2k
S. Victoria Otton Canada 15 262 1.9× 122 0.9× 55 0.6× 100 1.3× 13 0.2× 17 729
Andrew Mitchell Australia 20 124 0.9× 53 0.4× 110 1.3× 336 4.4× 83 1.2× 67 1.7k
R K Lynn United States 17 174 1.3× 83 0.6× 417 4.8× 181 2.4× 31 0.5× 47 1.0k
Lawrence J. Fischer United States 17 88 0.6× 75 0.6× 93 1.1× 124 1.6× 111 1.6× 35 849
Yael Lurie Israel 13 60 0.4× 74 0.6× 22 0.3× 104 1.4× 54 0.8× 29 605

Countries citing papers authored by MD Rawlins

Since Specialization
Citations

This map shows the geographic impact of MD Rawlins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MD Rawlins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MD Rawlins more than expected).

Fields of papers citing papers by MD Rawlins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MD Rawlins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MD Rawlins. The network helps show where MD Rawlins may publish in the future.

Co-authorship network of co-authors of MD Rawlins

This figure shows the co-authorship network connecting the top 25 collaborators of MD Rawlins. A scholar is included among the top collaborators of MD Rawlins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MD Rawlins. MD Rawlins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bull, Joseph W., Niels Jobstvogt, Anne Böhnke-Henrichs, et al.. (2015). Strengths, Weaknesses, Opportunities and Threats: A SWOT analysis of the ecosystem services framework. Ecosystem Services. 17. 99–111. 125 indexed citations
2.
Seymour, R. A., et al.. (1994). The efficacy of locally applied morphine in post‐operative pain after bilateral third molar surgery.. British Journal of Clinical Pharmacology. 37(3). 227–230. 19 indexed citations
3.
Rawlins, MD, et al.. (1991). Clinical pharmacology of prochlorperazine in healthy young males.. British Journal of Clinical Pharmacology. 32(6). 677–684. 38 indexed citations
4.
Edwards, C. A., et al.. (1991). Hospital prescribing and usage of hypnotics and anxiolytics.. British Journal of Clinical Pharmacology. 31(2). 190–192. 22 indexed citations
5.
Edwards, C. A., et al.. (1990). Lack of effect of co‐trimoxazole on the pharmacokinetics and pharmacodynamics of nifedipine.. British Journal of Clinical Pharmacology. 30(6). 889–891. 1 indexed citations
6.
Goudevenos, John, et al.. (1990). Hepatic drug clearance: the effect of age using indocyanine green as a model compound.. British Journal of Clinical Pharmacology. 30(4). 634–637. 49 indexed citations
7.
Moore, U., R. A. Seymour, E Mutch, et al.. (1989). Benorylate hydrolysis by human plasma and human liver.. British Journal of Clinical Pharmacology. 28(6). 703–708. 12 indexed citations
8.
Rawlins, MD, et al.. (1986). Pharmacodynamics and pharmacokinetics of single doses of ketanserin and propranolol alone and in combination in healthy volunteers.. British Journal of Clinical Pharmacology. 22(3). 301–308. 12 indexed citations
9.
Woodhouse, K. W., et al.. (1985). The metabolism of 7‐ethoxycoumarin in human liver microsomes and the effect of primary biliary cirrhosis: implications for studies of drug metabolism in liver disease.. British Journal of Clinical Pharmacology. 20(1). 77–80. 9 indexed citations
10.
Seymour, R. A., et al.. (1984). The efficacy and pharmacokinetics of sodium salicylate in post‐ operative dental pain.. British Journal of Clinical Pharmacology. 17(2). 161–163. 12 indexed citations
11.
Rawlins, MD, et al.. (1984). Reduction of antipyrine clearance in psoriasis.. British Journal of Clinical Pharmacology. 17(3). 331–333. 5 indexed citations
12.
Bateman, D. Nicholas, et al.. (1983). The acute and chronic effects of H1 receptor blockade with astemizole on indocyanine green clearance.. British Journal of Clinical Pharmacology. 16(3). 241–244. 4 indexed citations
13.
Mason, Geoffrey, MD Rawlins, & Sam Shuster. (1983). Blood monocyte aryl hydrocarbon hydroxylase activity in psoriasis.. British Journal of Clinical Pharmacology. 16(3). 333–335. 2 indexed citations
14.
Seymour, R. A. & MD Rawlins. (1982). Efficacy and pharmacokinetics of aspirin in post‐operative dental pain.. British Journal of Clinical Pharmacology. 13(6). 807–810. 49 indexed citations
15.
Mucklow, JC, et al.. (1982). The relationship between individual dietary constituents and antipyrine metabolism in Indo‐Pakistani immigrants to Britain.. British Journal of Clinical Pharmacology. 13(4). 481–486. 6 indexed citations
16.
Rawlins, MD, et al.. (1979). The activity of aryl hydrocarbon hydroxylase in adult human skin.. British Journal of Clinical Pharmacology. 7(5). 499–503. 25 indexed citations
17.
Rawlins, MD, et al.. (1979). A comparative study of methyldopa and labetalol in the treatment of hypertension.. British Journal of Clinical Pharmacology. 8(S2). 149S–151S. 11 indexed citations
18.
Routledge, PA, et al.. (1979). Pharmacokinetics and pharmacodynamics of warfarin at steady state.. British Journal of Clinical Pharmacology. 8(3). 243–247. 50 indexed citations
19.
Murray, Alan, et al.. (1979). Interdose control of beta‐blockade and arterial blood pressure during chronic oral labetalol treatment.. British Journal of Clinical Pharmacology. 8(S2). 125S–7S. 2 indexed citations
20.
Rawlins, MD, et al.. (1979). A multicentre open trial of labetalol in New Zealand.. British Journal of Clinical Pharmacology. 8(S2). 179S–182S. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michel Ollagnier Breakdown of academic impact, for papers by John A. H. Forrest Breakdown of academic impact, for papers by Teresa Cabaleiro Breakdown of academic impact, for papers by M. Lawrence Berman Breakdown of academic impact, for papers by S Freestone Breakdown of academic impact, for papers by S. Victoria Otton Breakdown of academic impact, for papers by Andrew Mitchell Breakdown of academic impact, for papers by R K Lynn Breakdown of academic impact, for papers by Lawrence J. Fischer Breakdown of academic impact, for papers by Yael Lurie
Rankless by CCL
2026